i-Target (@iTarget_ENB) header
i-Target (@iTarget_ENB) profile picture

International training program – Elite Network of Bavaria. Focusing on targeted cell-based therapies, targeted antibody therapy and immunomodulatory therapy

Joined December 2019
Challenges and Opportunities for Pancreatic Cancer Immunotherapy dlvr.it/Rndj8P
30
2
114
#CARTcell Therapie News vom #ASH20. Beim #ASHToday zusammengefasst von Prof. Peter Bader von der Uniklinik Frankfurt, Prof. Andreas Mackensen von der Uniklinik Erlangen, Prof. @MSubklewe vom @LMU_Uniklinikum und Prof. Simone Thomas von der @presse_ukr 👉 ash-today.de!
Congrats to Saskia on her successful PhD defense! One of the pioneers of our antibody subgroup and a great person and scientist!
2
1
24
Check out the poster by our PhD candidate @AnneMarieSenz on how IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models @ITOCconference @LMU_Uniklinikum @LMU_Muenchen @iTarget_ENB #Immunotherapy #CARTcells #IDO1 #PancreaticCancer
3
5
Welcome to the 7th Immunotherapy of Cancer Virtual Conference! Join us for our welcome address itoc2020.h82.eu/
3
4
Excited to hear about Synthetic agonistic receptor-activating BiTEs - a modular platform for the efficient targeting of acute myeloid leukemia from M.Res. Mohamed-Reda Benmebarek @BenmebarekMr on Saturday at @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #leukemia
2
3
Check out the poster from our medical student Carlotta Rambuscheck: Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma. Coming soon at @ITOCconference @LMU_Muenchen @LMU_Uniklinikum #ITOC7
4
4
Excited to hear Dr. Daniel Böhmer talk on how Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death @ITOCconference @LMU_Uniklinikum #PancreaticCancer #Immunotherapy #ITOC7 #CancerTherapy
4
4
Check out the poster from Dr. Bruno L. Cadilha @bcadilha : C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors. Coming soon @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #CARTcells #ITOC7 #CancerTherapy
2
3
Looking forward to Prof. Dr. Sebastian Kobolds talk on why adoptive T cells therapies fail for solid tumors. @ITOCconference on Saturday 3rd of October #Immunotherapy #cancerresearch #ITOC7 itoc-conference.eu/programme
3
3
One Week To Go! Join us for the ITOC7 Virtual Conference on Friday, October 2 and Saturday, October 3, 2020! itoc-conference.eu
Finally: Onkopedia Guidelines out on „CAR T Zellen: Management von Nebenwirkungen“; Thank you to all the contributors. onkopedia.com/de/onkopedia/g…
3
5
In our latest Viewpoint, Lars Koenig (@LM_Koenig) @KlinPharm and colleagues discuss the potential benefits of targeting CXCR2 in COVID-19 treatment. https://teapawt.net/t.co/diiH14rpxi #COVID19
1
4
1
21
🎉Congratulations!🎉 ... to Carolin Daniel from our #IDF for winning the 2020 "Early Career Research Prize in Vaccinology R&D" for her significant achievement in the field of Treg #vaccination in autoimmune #type1diabetes! 👏 ➡️iuis.org/news/we-have-a-winn…
6
3
34